Amicus Therapeutics
FOLD
#3212
Rank
โ‚ฌ3.93 B
Marketcap
12,52ย โ‚ฌ
Share price
-0.10%
Change (1 day)
57.85%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2025 (TTM): -0,09941ย โ‚ฌ

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,09553ย โ‚ฌ. In 2014 the company made an earnings per share (EPS) of -0,81ย โ‚ฌ.

EPS history for Amicus Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,09941ย โ‚ฌ
2014-0,81ย โ‚ฌ
2012-0,95ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
3,08ย โ‚ฌ-3,327.97%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
7,67ย โ‚ฌ-8,127.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
3,27ย โ‚ฌ-3,525.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-0,17ย โ‚ฌ 72.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,43ย โ‚ฌ 354.55%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1,58ย โ‚ฌ-1,754.55%๐Ÿ‡บ๐Ÿ‡ธ USA